These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 1377590)
21. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289 [TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin. Dohmen K; Shigematsu H; Irie K; Ishibashi H Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467 [TBL] [Abstract][Full Text] [Related]
23. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy. Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841 [TBL] [Abstract][Full Text] [Related]
24. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma]. Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741 [TBL] [Abstract][Full Text] [Related]
25. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630 [TBL] [Abstract][Full Text] [Related]
26. [Combined five tumor markers in detecting primary hepatic carcinoma]. Ma J; Gong Q; Lin M; Xi Y; Wang M; Chen Z; Pei Z; Ma W Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):14-6. PubMed ID: 11831976 [TBL] [Abstract][Full Text] [Related]
27. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
28. Alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma. Ballesta AM; Calvet X; Filella X; Bruix J; Bru C; Molina R; Rodes J J Nucl Med Allied Sci; 1989; 33(3 Suppl):39-41. PubMed ID: 2480420 [TBL] [Abstract][Full Text] [Related]
29. [Alpha-fetoprotein (AFP) variant in the diagnosis of small liver cancer]. Tu ZX; Wu MC; Cui ZF; Hu HK Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):191-3. PubMed ID: 2464465 [TBL] [Abstract][Full Text] [Related]
30. [Subject diagnostic value of detecting a1pha-fetoprotein variants with a new microspincolumn method in hepatocellular carcinoma]. Xu AF; Wang MC; Sui DM; Yuan YH; Chen G; Lou GQ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):67-9. PubMed ID: 17429541 [TBL] [Abstract][Full Text] [Related]
32. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study. Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626 [TBL] [Abstract][Full Text] [Related]
33. Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma. Moriwaki H; Yasuda I; Shiratori Y; Uematsu T; Okuno M; Muto Y Clin Cancer Res; 1997 May; 3(5):727-31. PubMed ID: 9815742 [TBL] [Abstract][Full Text] [Related]
34. [Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve]. Kim MJ; Bae KW; Seo PJ; Jeong IK; Kim JH; Lee BH; Bang KT; Kim DW; Song IH Korean J Hepatol; 2006 Sep; 12(3):404-11. PubMed ID: 16998292 [TBL] [Abstract][Full Text] [Related]
35. Lectin-reactive patterns of markedly elevated serum alpha-fetoprotein in patients with chronic active hepatitis. Koda M; Hori T; Maeda N; Kato S; Murawaki Y; Horie Y; Kawasaki H; Hirayama C; Taketa K Am J Gastroenterol; 1991 Jul; 86(7):861-5. PubMed ID: 1711775 [TBL] [Abstract][Full Text] [Related]
36. Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma. Baumann U; Duhme V; Auth MK; McKiernan PJ; Holme E J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):77-82. PubMed ID: 16819381 [TBL] [Abstract][Full Text] [Related]
37. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma. Peng YC; Chan CS; Chen GH Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187 [TBL] [Abstract][Full Text] [Related]
38. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study. Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963 [TBL] [Abstract][Full Text] [Related]
40. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Cui R; Wang B; Ding H; Shen H; Li Y; Chen X Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]